A former scientist at the FDA has revealed that the agency authorized Zyn nicotine pouches without fully understanding their composition. The approval process raised concerns about the safety and efficacy of these products, which are marketed as a smoke-free alternative to traditional tobacco. Zyn pouches contain nicotine derived from tobacco, but the exact ingredients and their potential health impacts were not thoroughly examined before the FDA granted approval.
The former scientist highlighted that this lack of scrutiny could pose risks to consumers who may not be aware of what they are ingesting. The FDA’s decision to approve Zyn has been criticized for prioritizing market access over comprehensive safety evaluations. As nicotine pouches gain popularity, there is growing pressure on regulatory agencies to ensure that all tobacco products undergo rigorous testing to protect public health.
Source: news.google.com